fbpx National Centre for Clinical Research on Emerging Drugs (NCCRED) | NDARC - National Drug and Alcohol Research Centre

National Centre for Clinical Research on Emerging Drugs (NCCRED)

The National Centre for Clinical research on Emerging Drugs (NCCRED) is an innovative, world-leading centre bringing together clinicians and researchers to detect and respond to trends in emerging drug health, including methamphetamine. NCCRED aims to collaborate in order to build the capacity and scope for new clinical research into emerging drugs; and rapidly translate these findings into best clinical practice. NCCRED is funded by the Commonwealth Department of Health through the National Ice Action Strategy (NIAS).
About the Program: 

NCCRED has three key aims:

  1. Collaborate to build scope and capacity for clinical research
  2. Generate new evidence-based knowledge
  3. Translate research into effective clinical practice

The strategies to achieve this include:

  • Building research capacity at a national level by conducting leading clinical research projects, awarding more than 1.5 million in seed and capacity building research grants, and inducting our first round of research fellows
  • Responding quickly to emerging trends by establishing a national Prompt Response Network (PRN), a Clinical Reference Group (CRG), and NCCRED Methamphetamine and Emerging Drugs Working Group (WG)
  • Developing clinical capacity of the AOD workforce through leading clinical guidelines and development strategies

To find out more about NCCRED, visit the NCCRED website or contact us.

Key projects

2020 NCCRED Symposium

NCCRED is hosting its second symposium online on 20th November 2020 – Innovations in therapeutic practice for methamphetamine use disorder. The program includes presentations from Round 2 Seed Funding Grants recipients, the NCCRED clinical research team and affiliates. This year’s international guest presenter is Dr David Goodman-Meza, Assistant Professor in the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA. To register go to the NCCRED website.

2020 Fellows Announced

NCCRED is opening TWO new competitive rounds which will give financial and research support, allowing recipients to conduct a new research project. Preferred candidates for this Scholarship round will be practising alcohol and other drugs nurses and allied health professionals, or practising Aboriginal or Torres Strait Islander health professionals (clinicians nurses, allied health workers). All scholarship applications will be selected from a competitive application process in Scholarship applications will be overseen by the NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group (WG) and the NCCRED Aboriginal and Torres Strait Islander Working Group (WG).

Further information is available within the application forms.

Open: 2 October 2020

Close: 6 November 2020

Notification: early December 2020

Contact us for more information. All expressions of interest are welcome.

Systematic Review of pharmacotherapies for methamphetamine dependence

NCCRED’s clinical research team has published an extensive systematic review of drug treatments for methamphetamine dependence. This is a comprehensive clinical resource for Health Care Workers wanting to know more about pharmacotherapies for MA dependence. It contains a matrix for current clinical pharmaceutical treatments for methamphetamine use disorder. The matrix can be viewed on the NCCRED website.

Good Clinical Practice (GCP)

NCCRED is seeking expressions of interest for a new round of GCP sessions for AOD workers. Please contact Florence Bascombe the NCCRED Knowledge Translation Lead for further info about coming sessions. f.bascombe@unsw.edu.au

S-Check App Trial

The S-Check App trial:  A research study into a smartphone app (S-Check) designed to help Australians manage their methamphetamine use is underway. The Stimulant Treatment Program at St Vincent’s Hospital Sydney (SVHS) has developed the S-Check App, based on the model of care at its S-Check Clinic. The App is a readily accessible tool for people who might not have access to regular treatment and support. The App is available to download for free on Google® Play or the Apple® App store. For more information on the S-Check App trial, visit www.scheckapp.org.au or contact Emily Li on svhs.scheckapptrial@svha.org.au.

Key resources

Clinical Guide for Methamphetamine
NCCRED has developed a clinical guide for primary health care professionals treating people who use methamphetamine. Read more.

Resources related to this Group